Company
Adaptimmune Therapeutics PLC (0001621227)
Standardized SEC financial data for Adaptimmune Therapeutics PLC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001621227 · Biological Products, (No Diagnostic Substances).
Gross margin
100.0%
Operating margin
-38.6%
Net margin
-39.8%
Revenue growth (YoY)
195.3%
Return on equity
-597.6%
Free cash flow
$72.3M
Debt / equity
4.58×
Current ratio
2.92×
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $4.0M | $6.1M | $27.1M | $60.3M | $178.0M |
| Cost of revenue |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.9M | $61.5M | $151.7M | $109.6M | $147.0M | $93.2M |
| Inventory |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$112.5M | -$53.6M | $10.7M | -$141.8M | -$140.9M | -$73.2M |
| Capital expenditures |
Get 0001621227 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001621227/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001621227/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"